chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I've had symptoms of leg pain/tenderness in my left leg after each of the two doses. The first time I thought it was due to not resting enough and overworking, but there was no possibility of that after the second dose on May 11th. I have been resting as much as possible and trying to alternate heat/ice therapy and seems to be helping, but am worried what I have may be blood clots. I do not have a primary physician at this time but am now looking.
Mother, misrepresented daughters DOB on the consent and release and in verbal communication before vaccine that patient was 12.  She stated year of birth was 2009 and actual date of birth was 2011.
Within 24 hours of receiving vaccine experienced unilateral facial numbness, resolved within 1 wk.  Experienced same type of event with both HPV #1 + HPV #2.  Saw neurologist for consultation, CT scan negative, facial palsy resolved on its own.  No specific neuro.  Follow up recommended.
PATIENT STATES THATS PATIENT IS VERY LIGHT HEADED AND FUZZY HEADED FEELING.
Pt said 05/23/12 she awoke to red, swelling and achy on her (R) deltoid (site of the injection). She was chilled 43mm wide and 50 mm long.
who administered the booster shot to her son accidentally rubbed it; booster dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a program (159558). The reporter is the parent.  A male patient received bnt162b2 (BNT162B2), administration date 22Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunization. Relevant medical history included PTSD (unspecified if ongoing); covid, start date: Mar2020 (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization.  The following information was reported CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious) with onset 22Nov2021, outcome unknown; IMMUNISATION (non-serious) with onset 22Nov2021, outcome unknown. Caller said that her son had severe PTSD. They had covid last Mar2020. And they already got the vaccine, both doses. And she mentioned that her son got his booster dose yesterday, and she is worried about the injection site because the person who administered the booster shot to her son accidentally rubbed it.  The lot number for bnt162b2 was not provided and will be requested during follow up. Linked Report(s): US-PFIZER_INC-202101655502 Same reporter, different patient.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 11-AUG-2015, the patient was vaccinated with an improperly stored dose of GARDASIL 9, 0.5 ml injection, lot # L007495 with expiration date 24-FEB-2017 (route and dose were not reported). This specified lot number vaccine was exposed to temperature excursion. The storage criteria was refrigerator (R). The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) was 152, 31 and R, respectively. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 23-MAY-2013, a pharmacist administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 09-APR-2015, the patient was treated by a physician for post herpetic neuralgia. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Mom states child had shots started itching 9 days later 9/24/08 child broke out with bumps mostly on arms. Broke out with more bumps itches. No fever.
severe chest pain.  Diagnosis possible pericarditis 2 weeks after vaccine and 3 weeks after seasonal flu vaccine given at same facility
numbness in fingers toes, lips, dizziness extreme fatigue, swollen cheeks;
Severe arm pain and soreness left deltoid up to three weeks later interfering with sleep. Mobic prescribed, 15mg p.o. daily X 2 weeks.
Broke out in hives in evening all over body. Given Benadryl, little relief. Seen by MD on 09/18/2001. IM Solu-medrol and no improvement. Referral to allergist. Seen 09/19/2001. Allergist prescribed Allegra and Zyrtec. Zyrtec to be used in evening if no improvement after Allegra. Rash remained on 09/20/2001. Itching somewhat better. History of allergic reaction in past to food and other allergens. Allergist desires to see child in one month and will test to see if child hypersensitive to vaccine per mother. Mother child to complete hep A series but advised her to follow advise of physician on that issue. Sent mother information on components in vaccines and study history from manufacturer. Was to call back in if rash worsened. No call received.
injection site sore; rashes; Light headache; dizziness; This is a Spontaneous report from Pfizer Support program. A contactable female consumer (reported for herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 27Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. on an unspecified date in 2021, the patient experienced injection site sore, rashes, light headache and dizziness. The second dose was scheduled on 18Apr2021. The outcome of the events was unknown.  No follow-up attempts are possible; Information on the lot/batch number has been requested.
Patient contact the office and complained of Body Chills lasting from 8:00 pm 9/23/2022 to 4:00am 9/24/2022. Patient says she was unable to sleep for the duration of the symptoms. Denied body aches, fever, nausea or vomiting.
WOKE UP AT 3 AM WITH CHILLS AND FEVER OF 103.  HAD VERY SORE ARM, HAD PAIN UNDER ARM IN THE ARM PIT WHEN PUTTING ON DEODERANT FOR 5 DAYS AFTER SHOT, HAD SEVERE HEADACHE, BODY ACHES, CHILLS, NAUSEA, AND BACK PAIN.  THIS LASTED ALL DAY SATURDAY AND SOME OF SUNDAY MORNING, THEN WAS FINE FOR THE DAY, BUT IT CAME BACK SUNDAY NIGHT.   WAS FINE BY MONDAY MORNING.
Symptoms ? EE reports he received his 2nd dose and reported to work from 11:00 PM shift.  EE reports pain at this injection site with shoulder pain that worsened as his shift went on.  EE reports pain as ?stabbing and sharp.?  EE reports he suffers from severe anxiety and takes medication for his anxiety.  EE reporting nausea at time of call but EE attributing to his anxiety as he often feels nauseated when he is anxious.  ?  Last day of work and shift - ? 1/13 Home remedies? -   acetaminophen at 11:15 am (1/14/21) Any improvement? ? mild improvement Recommendation? EE encouraged to continue to monitor his symptoms and to contact the vaccine support line for further questions or concerns.  EE encouraged to apply cold compress to injection site and neck and to rotate Tylenol and motrin q3h using dosing as instructed in Medical Directive.   EE verbalized back understanding and denied further questions at this time.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 63-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included Shingles vaccine (received in October 2018). On 22nd March 2019, the patient received the 1st dose of SHINGRIX. On 24th March 2019, 2 days after receiving SHINGRIX, the patient experienced pain in arm and neck pain. On an unknown date, the outcome of the pain in arm and neck pain were not recovered/not resolved. It was unknown if the reporter considered the pain in arm and neck pain to be related to SHINGRIX. Additional details were provided as follows: Previously, the patient received a shingles vaccination that was not SHINGRIX, the patient was unable to verify brand. After receiving 1st SHINGRIX dose on Friday, the patient experienced an achy arm and neck. On Sunday, symptoms of achy arm and neck got started and had not resolved. The patient did not consent to follow-up with physician.
vasovagal episode less than 20 seconds w rapid return to baseline.  History of syncope w ?needles? 2x in past.
Several hours after receiving vaccine I had chills developed fever 102.4, and experienced diarrhea and nausea as well as having severe headache
R-6th Nerve palsy, sx started 11-26-09 neuro visit 11-27-09, MRI, MRA, CBC, CMP, No change in sx by 12-7-09
patient received his vaccine 1/28/2021.  on 2/1/2021 it was noted that his platelet count was 7, previously on 1/8/2021 his platelets were 198.  patient was seen and evaluated by a hematologist.  platelets rechecked 2/8/2021 and they were 8.
This spontaneous report as received from an unspecified reporter via TELERX refers to a 48 years old male patient, who was vaccinated with a dose of ZOSTAVAX (lot# and dose not reported) on 09-NOV-2012. No side effects were reported. Additional information has been requested.
Some redness developed 24 hrs after injection, then dramatically worsened. At time of exam (44 hrs after injections), erythema, induration 21x19cm L ant thigh with patch of vesicles medial to injection site. Fever 101 at most, locally 99-100.
flu-like symptoms, chills, no fever, muscle aches, headache, dry cough, lethargy, loss of appetite
Systemic: Fainting / Unresponsive-Severe, Systemic: Shakiness-Mild, Additional Details: As soon as the vaccine was given, pt immediately passed out. Patient then began mildly shaking, this is when I administered the epipen.
Friday - Shot administered, waiting 15 min and felt fine.  Started having a headache, body aches, and nausea around 10 AM Saturday.  Felt lethargic all day and ran a fever.  Had bad joint pains and muscle cramps with fever and headache all through the night Saturday night. Sunday - still had a headache and felt very lethargic -  was cold and slept most of the day but did not have body aches.  Monday - woke up with another headache - took ibuprofen and seem to be feeling better.  Arm that shot was administered is still very sore.
8/4/21: Admitted to Hospital due to weakness and frequent falls. Patient tested positive for COVID-19 1 week ago, his 1st symptoms began 2 days prior, which included some mild shortness of breath, on Friday the 30th the patient got a regeneron infusion for COVID. Patient stated after receiving infusion on Friday he spent most of the subsequent weekend in bed secondary to increased fatigue. Note: patient previously vaccinated with Pfizer COVID-19 vaccine on 2/16/21 and 3/9/2021. 8/5/21: discharged.
Due to a paperwork calculation error the patient received the wrong vaccine for his age.  The orange top vial (5-11 yo) was given to the patient when he should have gotten the maroon top vial.  On 10/10/22, when the error was noticed upon entering all the paperwork into the computer system, the patient was contacted and did not have any adverse event.
FEW SIDE EFFECTS; FELT A LITTLE TIRED; This spontaneous report received from a consumer concerned an adult of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. On an unspecified date, the patient experienced few side effects, and felt a little tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the few side effects and felt a little tired was not reported. This report was non-serious.
Headache and general tiredness began 30-45 min after shot.  Muscle soreness (injection site, rib muscles, leg muscles, back muscles and neck muscles) began soon after.  By 6pm, muscles had become painful.  I had chills but no measurable fever.  I got in the bed but unable to sleep due to muscle pain and discomfort.  Hip joints and back began to ache.  Fever and chills worsened over the next several hours to measurable with highest at 102F.  I took 1000mg tylenol generic which did not lower fever but fever did not rise higher.  Throughout the night, I experienced calf muscle cramps and foot cramps, stomach pains, joint pains, inability to sleep, worsening injection site soreness and armpit soreness (likely lymph node soreness).  Once in middle of night I may have felt chest tightness but I even doubted that I really experienced it as I had been thinking about all the AEs I was experiencing.  Symptoms continued through night.  Next morning, developed a cough so I made appointment to get a COVID exposure test at 1pm on 13th April because I had flown in plane on 10th April.   Cough could have been due to allergy type post-nasal drip because of high pollen in area.  By late Tue evening, I felt better.  Headache had resolved and muscle symptoms improved.  Now (3:45pm on 15th April) I am still experiencing lymph node/armpit soreness and general inability to focus, think clearly.  I feel like I am in a fog.  I emailed a message to my physician and reported this through VAERS
Sore Throat, Nasal congestion, Body aches, x 3 days, headache x 2weeks  Fatigue x approx 10 days.
Fever (100.6) for 2 days, chills, sore arm, redness at injection site
This case was reported by a consumer via call center representative and described the occurrence of pruritus in a 59-year-old female patient who received SHINGRIX for prophylaxis. In July 2018, the patient received the 1st dose of SHINGRIX. In July 2018, 7 days after receiving SHINGRIX, the patient experienced pruritus. On an unknown date, the outcome of the pruritus was recovering/resolving. It was unknown if the reporter considered the pruritus to be related to SHINGRIX. Additional details were provided as follows: The patient was the cousin of reporter. The patient contacted the reporter via text. The age at vaccination was not reported. But, it could be 58 or 59 years old. The patient received the SHINGRIX vaccine about 3 weeks before the date of reporting, about one week after receiving the SHINGRIX, the patient experienced itching (not at the injection site) which got less. The itching started on the ankles and shins and moved to the wrists and forearms. She also had itching on the upper neck and face (below eyes to the ears). The itching was first quite aggressive after a week it was almost gone. The only place she still had active itching was on her face at the time of reporting. The reporter did not obtain consent to file a report. The reporter did not ask for doctor of medicine (MD) contact information.
Severe site reaction. Fever greater than or equal to 104 degrees F. Neck tightness. Passing out/black out. Body aches. Possible cellulitis. Flu-like symptoms. ER visit.
Large red swelling, hard spot, sore, feverish at spot, pain up and down arm to fingers.
Approximately 1/2 hour after receiving H1N1 client had facial swelling, wheezing, rash on chest, and shortness of breath. Given epinephrine 3 mg. 911 notified and client was transported to hospital. 11/10/2009 Ed records from 11/5/2009. Patient with c/o's facial swelling, SOB, rash. Tx: IV Steroids, Benadryl, Pepcid and Zantac. DC Dx: Allergic reaction
July 1, 2022 I had a runny nose, cough and a little headache. I had no fever. I took a home COVID test that was negative. I took a second COVID home test on 7/2/2022 and it was positive. These symptoms continued for a few days and gradually disappeared. I have recovered. Roughly a week later, I took another home Covid test that was negative.
Patient complained of arm and shoulder pain (dull and sharp pains combined) that comes and goes. It is not a constant issue but certain movements do aggravate the area. The pain subsides after awhile.
No adverse event; Monovalent doses administered after the BUD to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) in a 58-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 065K21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Jun-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 02-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Monovalent doses administered after the BUD to patients).    Concomitant medication was not reported. Treatment medication was not reported.
Whole body became red, swollen, itchy, throat closing up, felt like I had a severe sunburn, anaphylactic allergy
Information has been received from a medical assistant concerning a female patient who on an unspecified date received the second dose of GARDASIL (lot#, route and injection site not reported). After the vaccination she fainted. It was unknown if the patient sought medical attention or not. Outcome of the event was not provided. Additional information has been requested. This is one of two reports received from a same source.
Pain/sharp achy pain; Edema / swelling in arm pit and above her left breast / edema under her left arm pit; Having sharp and aching pain on the left side of my back and where I got the injection; My armpit and my left shoulder and the scalene muscles have pain down to my hands; My armpit and my left shoulder and the scalene muscles have pain down to my hands; My armpit and my left shoulder and the scalene muscles have pain down to my hands; My armpit and my left shoulder and the scalene muscles have pain down to my hands; it made me sicker than I was when I had it / didn't feel well  / feeling fairly ill / general malaise; Persisting, they were a little better and now they are worse again; chest pain that went to her back; extreme fatigue; nausea; This is a spontaneous report from a contactable nurse (patient). A 69-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6206; expiry: unknown), dose 1 intramuscular on 29Mar2021 as dose 1, single for covid-19 immunisation. Medical history included fibromyalgia, migraine headache, COVID and Pneumonia. Concomitant medication included duloxetine (60 mg twice a day). The patient had my first dose and her symptoms are worsened than when she got COVID and pneumonia. The patient experienced pain/sharp achy pain, edema/swelling in arm pit and above her left breast/ edema under her left arm pit, having sharp and aching pain on the left side of my back and where i got the injection, my armpit and my left shoulder and the scalene muscles have pain down to my hands, it made me sicker than i was when i had it / didn't feel well/ feeling fairly ill / general malaise, persisting, they were a little better and now they are worse again, chest pain that went to her back, extreme fatigue, nausea on an unspecified date. She took the first dose and was feeling fairly ill after the first dose, received on 29Mar2021, had swelling in arm pit and above her left breast and the physician ordered tests for that, states she has not taken the second dose of the vaccine and what she needed to know is if she should go ahead an take it or take both doses again. The patient stated that "Persisting, they were a little better and now they are worse again." Treatment was received in response to event, Aleve, 200 mg capsule. took it twice. The outcome of events was unknown.  Follow-up attempts are completed. No further information is expected.
Initial information received on 22-Oct-2018 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves seven Elderly patient of Unknown demographics who experienced big red baseball size swollen area on arms and hot to touch and soreness, while he/she received vaccine FLUZONE HIGH DOSE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant Mediation was not reported. On an unknown date, the patients received a 0.5 ml dose of suspect FLUZONE HIGH DOSE lot UJ039AA expiry date: 15-May-2018 via intramuscular route. On an unknown date, the patients developed a non-serious big red baseball size swollen area on arms (inflammation) following the administration of FLUZONE HIGH DOSE. (Other relevant tests included No lab data.)Final diagnosis was hot to touch and soreness and big red baseball size swollen area on arms. It was not reported if the patients received a corrective treatment. The patient outcome is reported as Unknown for big red baseball size swollen area on arms, hot to touch and soreness. List of documents held by sender: none.
Rash, pain in area of injection 1 day after injection. Achy, no fever.
Patient reports that approximately 1 week after receiving first dose, she developed a rash below the injection site.  It was a red oval area below the injection site. It was itchy but no pain. Treated with body lotion.  Lasted 4-5 days, then went away.
Child's father filled out the consent form and for DOB include only Day and Month, then hand wrote 12 years next to this.  Pharmacy intern administered the vaccination to the child.  Minutes later while typing up the record the pharmacy team noticed that the child already had a profile in the computer system and that the child was in fact 11 years and 10 months.  Pharmacy team approached the father about this who then stated that his wife is a medical professional and that it was okay.  The pharmacy team explained that they would not be able to provide a 2nd vaccination to the child until he turns 12.